Table 4 Clinical outcomes after PCC administration (haemostasis and survival)
Indication | Haemostasis | Survival | |||||
|---|---|---|---|---|---|---|---|
| Â | Complete | Partial | Not achieved | Not recorded | Death not related to bleeding | Death related to bleeding | Alive after episode |
Cardiac surgery (CABG; n = 5) | 2 (40%) | 2 (40%) | 0 (0%) | 1 (20%) | 2 (40%) | 1 (20%) | 2 (40%) |
Cardiac surgery (valve replacement; n = 2) | 0 (0%) | 2 (100%) | 0 (0%) | 0 (0%) | 1 (50%) | 0 (0%) | 1 (50%) |
Other surgery (n = 9) | 1 (11.1%) | 5 (55.6%) | 1 (11.1%) | 2 (22.2%) | 4 (44.4%) | 2 (22.2%) | 3 (33.3%) |
Warfarin reversal (n = 8) | 2 (25%) | 0 (0%) | 3 (37.5%) | 3 (37.5%) | 1 (12.5%) | 1 (12.5%) | 6 (75%) |
All patients (n = 24) | 5 (20.8%) | 9 (37.5%) | 4 (16.7%) | 6 (25.0%) | 8 (33.3%) | 4 (16.6%) | 12 (50%) |